Advantages at a glance
- Pool of 31 peptides
- Purity: Each peptide ESI-MS checked, pool is purified by solid phase extraction.
- Amount: 25µg each peptide (775µg for complete pool)
- UniProt ID: P0DTC2
- Free shipping
- Shipping within 24h
- 30 days money back guarantee
- Purchase comfortable on account
Product information "Eta Variant (B.1.525) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)"
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020..
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.
This peptide pool is supplied lyophilized as trifluoroacetate salt.
Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2,5 x 108 cells):
KVFRSSVLHSTRDLF PFLGVHKNNKSWMES PIGAGICASYQTHTN SSVLHSTRDLFLPFF VHKNNKSWMESEFRV GICASYQTHTNSPRR HSTRDLFLPFFSNVT NKSWMESEFRVYSSA SYQTHTNSPRRARSV DLFLPFFSNVTWFHV
MESEFRVYSSANNCT HTNSPRRARSVASQS PFFSNVTWFHVISGT FRVYSSANNCTFEYV LLAGTITSGWTLGAG NVTWFHVISGTNGTK YQAGSTPCNGVKGFN TITSGWTLGAGAALQ FHVISGTNGTKRFDN STPCNGVKGFNCYFP
GWTLGAGAALQIPFA SGTNGTKRFDNPVLP NGVKGFNCYFPLQSY GTKRFDNPVLPFNDG GTNTSNQVAVLYQGV VIKVCEFQFCNDPFL SNQVAVLYQGVNCTE CEFQFCNDPFLGVHK AVLYQGVNCTEVPVA FCNDPFLGVHKNNKS
QGVNCTEVPVAIHAD
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)
| Gene: | S | |
| No Peptides: | 80 peptides | |
| Amount Peptide: | 25 µg | |
| Amount Aliquote: | 2,0 mg | |
| Uniprot Id: | P0DTC2 | |
| Solubility: | Dissolve in a minimum amount of pure DMSO (approx. 40μl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological | |
| Storage: | Store at -20°C | |
| Delivery: | 2-3 days | |
| Purity: | Each peptide ESI-MS checked, pool is purified by solid phase extraction | |
| Counter Ion: | TFA | |
| Protein: | Spike glycoprotein | |
| Species: | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Covid-19, Infection, Respiratory infection |
Application:
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.Source:
syntheticClassification:
Documents:
Product descriptionAccessory Items
This peptide pool of the omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations. Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response. Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts. Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT